Skip to main content
Erschienen in: Journal of Gastroenterology 2/2020

02.11.2019 | Original Article—Alimentary Tract

Short-term safety and efficacy of peroral endoscopic myotomy for the treatment of achalasia in children

verfasst von: Zuqiang Liu, Yun Wang, Ying Fang, Ying Huang, Hongbin Yang, Xiaoxia Ren, Meidong Xu, Shiyao Chen, Weifeng Chen, Yunshi Zhong, Yiqun Zhang, Wenzheng Qin, Jianwei Hu, Mingyan Cai, Liqing Yao, Quanlin Li, Pinghong Zhou

Erschienen in: Journal of Gastroenterology | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Peroral endoscopic myotomy (POEM) has shown excellent results for the treatment of achalasia in adults, but studies for children are limited. The study was aimed to analyze outcomes of peroral endoscopic myotomy (POEM) in children and compared with those in adults in a large multi-center study.

Methods

Records of consecutive patients with achalasia who underwent POEM at three tertiary centers were reviewed. A total of 130 children were included in this study. The primary outcomes of perioperative outcomes and clinical follow-up data were analyzed.

Results

One child (0.8%) experienced technical failure. Five children (3.8%) had major adverse events, including one with pneumothorax requiring drainage, two with delayed mucosa barrier failure, one with readmission, and one with vital-sign instability. Both post-POEM Eckardt score and median LES pressure were significantly lower than their pre-POEM reference values in children (0.7 vs 7.4; 7.0 vs 27.1 mmHg; both P < 0.001). During a median follow-up time of 40 months, clinical reflux rate was 27.0% and clinical failure rates at 1, 3, and 5 years were 1.8%, 3.5%, and 4.4% for children. The technical failure, major adverse events, and postoperative clinical reflux were comparable between children and adults (all P > 0.05). Kaplan–Meier analysis showed that the risk of clinical failure was lower in children than adults (log-rank test, hazard ratio = 0.37, 95% confidence interval 0.15–0.91, P = 0.023).

Conclusions

POEM can be safely performed in children with achalasia, and produce a better clinical response during long-term follow-up compared with that in adults.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Liu Z, Zhang X, Zhang W, et al. Comprehensive evaluation of the learning curve for peroral endoscopic myotomy. Clin Gastroenterol Hepatol. 2018;16(1420–1426):e2. Liu Z, Zhang X, Zhang W, et al. Comprehensive evaluation of the learning curve for peroral endoscopic myotomy. Clin Gastroenterol Hepatol. 2018;16(1420–1426):e2.
2.
Zurück zum Zitat Marlais M, Fishman JR, Fell JM, et al. UK incidence of achalasia: an 11-year national epidemiological study. Arch Dis Child. 2011;96:192–4.CrossRef Marlais M, Fishman JR, Fell JM, et al. UK incidence of achalasia: an 11-year national epidemiological study. Arch Dis Child. 2011;96:192–4.CrossRef
3.
Zurück zum Zitat Mayberry JF, Mayell MJ. Epidemiological study of achalasia in children. Gut. 1988;29:90–3.CrossRef Mayberry JF, Mayell MJ. Epidemiological study of achalasia in children. Gut. 1988;29:90–3.CrossRef
4.
Zurück zum Zitat Sato H, Yokomichi H, Takahashi K, et al. Epidemiological analysis of achalasia in Japan using a large-scale claims database. J Gastroenterol. 2019;54:621–7.CrossRef Sato H, Yokomichi H, Takahashi K, et al. Epidemiological analysis of achalasia in Japan using a large-scale claims database. J Gastroenterol. 2019;54:621–7.CrossRef
5.
Zurück zum Zitat Chen WF, Li QL, Zhou PH, et al. Long-term outcomes of peroral endoscopic myotomy for achalasia in pediatric patients: a prospective, single-center study. Gastrointest Endosc. 2015;81:91–100.CrossRef Chen WF, Li QL, Zhou PH, et al. Long-term outcomes of peroral endoscopic myotomy for achalasia in pediatric patients: a prospective, single-center study. Gastrointest Endosc. 2015;81:91–100.CrossRef
6.
Zurück zum Zitat Sato H, Takahashi K, Mizuno KI, et al. Esophageal motility disorders: new perspectives from high-resolution manometry and histopathology. J Gastroenterol. 2018;53:484–93.CrossRef Sato H, Takahashi K, Mizuno KI, et al. Esophageal motility disorders: new perspectives from high-resolution manometry and histopathology. J Gastroenterol. 2018;53:484–93.CrossRef
7.
Zurück zum Zitat Kahrilas PJ, Katzka D, Richter JE. Clinical practice update: the use of per-oral endoscopic myotomy in achalasia: expert review and best practice advice from the AGA institute. Gastroenterology. 2017;153:1205–11.CrossRef Kahrilas PJ, Katzka D, Richter JE. Clinical practice update: the use of per-oral endoscopic myotomy in achalasia: expert review and best practice advice from the AGA institute. Gastroenterology. 2017;153:1205–11.CrossRef
8.
Zurück zum Zitat Miao S, Wu J, Lu J, et al. Peroral endoscopic myotomy in children with achalasia: a relatively long-term single-center study. J Pediatr Gastroenterol Nutr. 2018;66:257–62.CrossRef Miao S, Wu J, Lu J, et al. Peroral endoscopic myotomy in children with achalasia: a relatively long-term single-center study. J Pediatr Gastroenterol Nutr. 2018;66:257–62.CrossRef
9.
Zurück zum Zitat Nabi Z, Ramchandani M, Reddy DN, et al. Per Oral endoscopic myotomy in children with achalasia cardia. J Neurogastroenterol Motil. 2016;22:613–9.CrossRef Nabi Z, Ramchandani M, Reddy DN, et al. Per Oral endoscopic myotomy in children with achalasia cardia. J Neurogastroenterol Motil. 2016;22:613–9.CrossRef
10.
Zurück zum Zitat Li C, Tan Y, Wang X, et al. Peroral endoscopic myotomy for treatment of achalasia in children and adolescents. J Pediatr Surg. 2015;50:201–5.CrossRef Li C, Tan Y, Wang X, et al. Peroral endoscopic myotomy for treatment of achalasia in children and adolescents. J Pediatr Surg. 2015;50:201–5.CrossRef
11.
Zurück zum Zitat Caldaro T, Familiari P, Romeo EF, et al. Treatment of esophageal achalasia in children: Today and tomorrow. J Pediatr Surg. 2015;50:726–30.CrossRef Caldaro T, Familiari P, Romeo EF, et al. Treatment of esophageal achalasia in children: Today and tomorrow. J Pediatr Surg. 2015;50:726–30.CrossRef
12.
Zurück zum Zitat Tan Y, Zhu H, Li C, et al. Comparison of peroral endoscopic myotomy and endoscopic balloon dilation for primary treatment of pediatric achalasia. J Pediatr Surg. 2016;51:1613–8.CrossRef Tan Y, Zhu H, Li C, et al. Comparison of peroral endoscopic myotomy and endoscopic balloon dilation for primary treatment of pediatric achalasia. J Pediatr Surg. 2016;51:1613–8.CrossRef
13.
Zurück zum Zitat Zhang XC, Li QL, Huang Y, et al. Peroral endoscopic myotomy using the posterior approach in an 11-month-old girl with achalasia, severe malnutrition, and recurrent pneumonia. Endoscopy. 2015;47(Suppl 1):E480–E482. (UCTN).PubMed Zhang XC, Li QL, Huang Y, et al. Peroral endoscopic myotomy using the posterior approach in an 11-month-old girl with achalasia, severe malnutrition, and recurrent pneumonia. Endoscopy. 2015;47(Suppl 1):E480–E482. (UCTN).PubMed
14.
Zurück zum Zitat Ren Y, Tang X, Chen Y, et al. Pre-treatment Eckardt score is a simple factor for predicting one-year peroral endoscopic myotomy failure in patients with achalasia. Surg Endosc. 2017;31:3234–41.CrossRef Ren Y, Tang X, Chen Y, et al. Pre-treatment Eckardt score is a simple factor for predicting one-year peroral endoscopic myotomy failure in patients with achalasia. Surg Endosc. 2017;31:3234–41.CrossRef
15.
Zurück zum Zitat Li QL, Zhou PH. Perspective on peroral endoscopic myotomy for achalasia: Zhongshan experience. Gut Liver. 2015;9:152–8.CrossRef Li QL, Zhou PH. Perspective on peroral endoscopic myotomy for achalasia: Zhongshan experience. Gut Liver. 2015;9:152–8.CrossRef
16.
Zurück zum Zitat Liu ZQ, Li QL, Chen WF, et al. The effect of prior treatment on clinical outcomes in patients with achalasia undergoing peroral endoscopic myotomy. Endoscopy. 2019;51:307–16.CrossRef Liu ZQ, Li QL, Chen WF, et al. The effect of prior treatment on clinical outcomes in patients with achalasia undergoing peroral endoscopic myotomy. Endoscopy. 2019;51:307–16.CrossRef
17.
Zurück zum Zitat Wu QN, Xu XY, Zhang XC, et al. Submucosal fibrosis in achalasia patients is a rare cause of aborted peroral endoscopic myotomy procedures. Endoscopy. 2017;49:736–44.CrossRef Wu QN, Xu XY, Zhang XC, et al. Submucosal fibrosis in achalasia patients is a rare cause of aborted peroral endoscopic myotomy procedures. Endoscopy. 2017;49:736–44.CrossRef
18.
Zurück zum Zitat Zhang XC, Li QL, Xu MD, et al. Major perioperative adverse events of peroral endoscopic myotomy: a systematic 5-year analysis. Endoscopy. 2016;48:967–78.CrossRef Zhang XC, Li QL, Xu MD, et al. Major perioperative adverse events of peroral endoscopic myotomy: a systematic 5-year analysis. Endoscopy. 2016;48:967–78.CrossRef
19.
Zurück zum Zitat Jones R, Junghard O, Dent J, et al. Development of the GerdQ, a tool for the diagnosis and management of gastro-oesophageal reflux disease in primary care. Aliment Pharmacol Ther. 2009;30:1030–8.CrossRef Jones R, Junghard O, Dent J, et al. Development of the GerdQ, a tool for the diagnosis and management of gastro-oesophageal reflux disease in primary care. Aliment Pharmacol Ther. 2009;30:1030–8.CrossRef
20.
Zurück zum Zitat Li QL, Wu QN, Zhang XC, et al. Outcomes of per-oral endoscopic myotomy for treatment of esophageal achalasia with a median follow-up of 49 months. Gastrointest Endosc. 2018;87(1405–1412):e3. Li QL, Wu QN, Zhang XC, et al. Outcomes of per-oral endoscopic myotomy for treatment of esophageal achalasia with a median follow-up of 49 months. Gastrointest Endosc. 2018;87(1405–1412):e3.
21.
Zurück zum Zitat Hassall E, Israel D, Shepherd R, et al. Omeprazole for treatment of chronic erosive esophagitis in children: a multicenter study of efficacy, safety, tolerability and dose requirements International Pediatric Omeprazole Study Group. J Pediatr. 2000;137:800–7.CrossRef Hassall E, Israel D, Shepherd R, et al. Omeprazole for treatment of chronic erosive esophagitis in children: a multicenter study of efficacy, safety, tolerability and dose requirements International Pediatric Omeprazole Study Group. J Pediatr. 2000;137:800–7.CrossRef
22.
Zurück zum Zitat Poddar U. Gastroesophageal reflux disease (GERD) in children. Paediatr Int Child Health. 2019;39:7–12.CrossRef Poddar U. Gastroesophageal reflux disease (GERD) in children. Paediatr Int Child Health. 2019;39:7–12.CrossRef
23.
Zurück zum Zitat Nikaki K, Woodland P, Sifrim D. Adult and paediatric GERD: diagnosis, phenotypes and avoidance of excess treatments. Nat Rev Gastroenterol Hepatol. 2016;13:529–42.CrossRef Nikaki K, Woodland P, Sifrim D. Adult and paediatric GERD: diagnosis, phenotypes and avoidance of excess treatments. Nat Rev Gastroenterol Hepatol. 2016;13:529–42.CrossRef
24.
Zurück zum Zitat Hurwitz M, Bahar RJ, Ament ME, et al. Evaluation of the use of botulinum toxin in children with achalasia. J Pediatr Gastroenterol Nutr. 2000;30:509–14.CrossRef Hurwitz M, Bahar RJ, Ament ME, et al. Evaluation of the use of botulinum toxin in children with achalasia. J Pediatr Gastroenterol Nutr. 2000;30:509–14.CrossRef
25.
Zurück zum Zitat Ip KS, Cameron DJ, Catto-Smith AG, et al. Botulinum toxin for achalasia in children. J Gastroenterol Hepatol. 2000;15:1100–4.CrossRef Ip KS, Cameron DJ, Catto-Smith AG, et al. Botulinum toxin for achalasia in children. J Gastroenterol Hepatol. 2000;15:1100–4.CrossRef
26.
Zurück zum Zitat Anselmino M, Perdikis G, Hinder RA, et al. Heller myotomy is superior to dilatation for the treatment of early achalasia. Arch Surg. 1997;132:233–40.CrossRef Anselmino M, Perdikis G, Hinder RA, et al. Heller myotomy is superior to dilatation for the treatment of early achalasia. Arch Surg. 1997;132:233–40.CrossRef
27.
Zurück zum Zitat Askegard-Giesmann JR, Grams JM, Hanna AM, et al. Minimally invasive Heller's myotomy in children: safe and effective. J Pediatr Surg. 2009;44:909–11.CrossRef Askegard-Giesmann JR, Grams JM, Hanna AM, et al. Minimally invasive Heller's myotomy in children: safe and effective. J Pediatr Surg. 2009;44:909–11.CrossRef
28.
Zurück zum Zitat Corda L, Pacilli M, Clarke S, et al. Laparoscopic oesophageal cardiomyotomy without fundoplication in children with achalasia: a 10-year experience: a retrospective review of the results of laparoscopic oesophageal cardiomyotomy without an anti-reflux procedure in children with achalasia. Surg Endosc. 2010;24:40–4.CrossRef Corda L, Pacilli M, Clarke S, et al. Laparoscopic oesophageal cardiomyotomy without fundoplication in children with achalasia: a 10-year experience: a retrospective review of the results of laparoscopic oesophageal cardiomyotomy without an anti-reflux procedure in children with achalasia. Surg Endosc. 2010;24:40–4.CrossRef
29.
Zurück zum Zitat Maselli R, Inoue H, Misawa M, et al. Peroral endoscopic myotomy (POEM) in a 3-year-old girl with severe growth retardation, achalasia, and Down syndrome. Endoscopy. 2012;44(Suppl 2):E285–E287287.PubMed Maselli R, Inoue H, Misawa M, et al. Peroral endoscopic myotomy (POEM) in a 3-year-old girl with severe growth retardation, achalasia, and Down syndrome. Endoscopy. 2012;44(Suppl 2):E285–E287287.PubMed
30.
Zurück zum Zitat Bechara R, Onimaru M, Ikeda H, et al. Per-oral endoscopic myotomy, 1000 cases later: pearls, pitfalls, and practical considerations. Gastrointest Endosc. 2016;84:330–8.CrossRef Bechara R, Onimaru M, Ikeda H, et al. Per-oral endoscopic myotomy, 1000 cases later: pearls, pitfalls, and practical considerations. Gastrointest Endosc. 2016;84:330–8.CrossRef
31.
Zurück zum Zitat Nabi Z, Ramchandani M, Chavan R, et al. Peroral endoscopic myotomy in treatment-naive achalasia patients versus prior treatment failure cases. Endoscopy. 2018;50:358–70.CrossRef Nabi Z, Ramchandani M, Chavan R, et al. Peroral endoscopic myotomy in treatment-naive achalasia patients versus prior treatment failure cases. Endoscopy. 2018;50:358–70.CrossRef
32.
Zurück zum Zitat Ngamruengphong S, Inoue H, Ujiki MB, et al. Efficacy and safety of peroral endoscopic myotomy for treatment of achalasia after failed heller myotomy. Clin Gastroenterol Hepatol. 2017;15(1531–1537):e3. Ngamruengphong S, Inoue H, Ujiki MB, et al. Efficacy and safety of peroral endoscopic myotomy for treatment of achalasia after failed heller myotomy. Clin Gastroenterol Hepatol. 2017;15(1531–1537):e3.
33.
Zurück zum Zitat Sherman RE, Anderson SA, Dal Pan GJ, et al. Real-world evidence—What Is It and What can it tell us? N Engl J Med. 2016;375:2293–7.CrossRef Sherman RE, Anderson SA, Dal Pan GJ, et al. Real-world evidence—What Is It and What can it tell us? N Engl J Med. 2016;375:2293–7.CrossRef
Metadaten
Titel
Short-term safety and efficacy of peroral endoscopic myotomy for the treatment of achalasia in children
verfasst von
Zuqiang Liu
Yun Wang
Ying Fang
Ying Huang
Hongbin Yang
Xiaoxia Ren
Meidong Xu
Shiyao Chen
Weifeng Chen
Yunshi Zhong
Yiqun Zhang
Wenzheng Qin
Jianwei Hu
Mingyan Cai
Liqing Yao
Quanlin Li
Pinghong Zhou
Publikationsdatum
02.11.2019
Verlag
Springer Singapore
Erschienen in
Journal of Gastroenterology / Ausgabe 2/2020
Print ISSN: 0944-1174
Elektronische ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-019-01607-4

Weitere Artikel der Ausgabe 2/2020

Journal of Gastroenterology 2/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.